Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-12

Clinical Trial Update: Novel Targetable BIOmarkers in ANorexia NervosA

View source ↗

Summary

A clinical trial from University Hospital Basel is investigating novel targetable biomarkers in anorexia nervosa and is currently recruiting. The study aims to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Anorexia Nervosa, Anorexia Nervosa Restricting Type | Status: RECRUITING